Dr Reddys Laboratories (RDY) Cash from Operations (2009)

Dr Reddys Laboratories (RDY) posted quarterly Cash from Operations of 58000000.0 for Q4 2009, down 36.96% on a QoQ basis from 92000000.0 in Q3 2009.

Dr Reddys Laboratories (RDY) Cash from Operations (2009) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Cash from Operations for 1 consecutive years, with 58000000.0 the latest figure, recorded in Q4 2009.

Quarterly Cash from Operations changed N/A year-over-year to 58000000.0 in Q4 2009, while the trailing twelve-month figure through Dec 2009 was 236316000.0 (changed N/A YoY) and the FY2026 annual result came in at 607000000.0, up 11.38% from the prior year.
Cash from Operations eased to 58000000.0 in Q4 2009 per RDY's latest filing, from 92000000.0 in the prior quarter.
Over the last five years, Cash from Operations for RDY reached as high as 96000000.0 in Q2 2009 and fell as low as 58000000.0 in Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Operations (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-40.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	401.00 Mn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	1.58 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	463.30 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	388.30 Mn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	145.80 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	13.00 Mn
10	Dr Reddys Laboratories	9.82 Bn	9.66 Bn	-	-

Download Data